Cargando…

Thromboembolic Events During Treatment with Cisplatin-based Chemotherapy in Metastatic Testicular Germ-cell Cancer 2000–2014: A Population-based Cohort Study

BACKGROUND: Cisplatin-based chemotherapy (CBCT) in testicular cancer (TC) is associated with elevated venous thromboembolism (VTE) risk, but trials evaluating the safety and efficacy of thromboprophylaxis are lacking. OBJECTIVE: To evaluate the arterial thromboembolism (ATE) and VTE incidence and ri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Haugnes, Hege S., Negaard, Helene F., Jensvoll, Hilde, Wilsgaard, Tom, Tandstad, Torgrim, Solberg, Arne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Testis Cancer
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505199/ https://www.ncbi.nlm.nih.gov/pubmed/34667955 http://dx.doi.org/10.1016/j.euros.2021.07.007

Ejemplares similares

Safety of Minimizing Intensity of Follow-up on Active Surveillance for Clinical Stage I Testicular Germ Cell Tumors
por: Gariscsak, Peter J., et al.
Publicado: (2022)

DDX4-EGFP transgenic rat model for the study of germline development and spermatogenesis (†)
por: Gassei, Kathrin, et al.
Publicado: (2017)

The SMC5/6 Complex Is Involved in Crucial Processes During Human Spermatogenesis(1)
por: Verver, Dideke E., et al.
Publicado: (2014)

Different expression patterns of sperm motility-related genes in testis of diploid and tetraploid cyprinid fish(†)
por: Hu, Fangzhou, et al.
Publicado: (2017)

Paclitaxel, Ifosfamide, and Cisplatin in Patients with Poor-prognosis Disseminated Nonseminomatous Germ Cell Tumors with Unfavorable Serum Tumor Marker Decline After First Cycle of Chemotherapy. The GCT-SK-003 Phase II Trial
por: Mego, Michal, et al.
Publicado: (2021)

Oncological Follow-up Strategies for Testicular Germ Cell Tumours: A Narrative Review
por: Kaufmann, Ernest, et al.
Publicado: (2022)

Features and Management of Late Relapse of Nonseminomatous Germ Cell Tumour
por: Jay, Alexander P.M., et al.
Publicado: (2021)

Increase and Plateauing of Testicular Cancer Incidence in Austria—A Time Trend Analysis of the Past Four Decades
por: Brönimann, Stephan, et al.
Publicado: (2023)

Causes of inferior relative survival after testicular germ cell tumor diagnosed 1953–2015: A population-based prospective cohort study
por: Kvammen, Øivind, et al.
Publicado: (2019)

Long-term Testis Cancer Survivors in Canada—Mortality Risks in a Large Population-based Cohort
por: Lavi, Arnon, et al.
Publicado: (2020)

Cancer therapy and risk of congenital malformations in children fathered by men treated for testicular germ-cell cancer: A nationwide register study
por: Al-Jebari, Yahia, et al.
Publicado: (2019)

Nerve-sparing Robot-assisted Retroperitoneal Lymph Node Dissection: The Monoblock Technique
por: Afferi, Luca, et al.
Publicado: (2021)

Outcomes of Postchemotherapy Retroperitoneal Lymph Node Dissection from a High-volume UK Centre Compared with a National Data Set
por: Pearce, Adam Kieran, et al.
Publicado: (2021)

A Randomised Phase 2 Trial of Intensive Induction Chemotherapy (CBOP/BEP) and Standard BEP in Poor-prognosis Germ Cell Tumours (MRC TE23, CRUK 05/014, ISRCTN 53643604)
por: Huddart, Robert A., et al.
Publicado: (2015)

Management of penile cancer patients during the COVID-19 pandemic: An eUROGEN accelerated Delphi consensus study
por: Cakir, Omer Onur, et al.
Publicado: (2021)

The cardiac impact of cisplatin-based chemotherapy in survivors of testicular cancer: a 30-year follow-up
por: Bjerring, Anders W, et al.
Publicado: (2020)

Cisplatin treatment of testicular cancer patients introduces long-term changes in the epigenome
por: Bucher-Johannessen, Cecilie, et al.
Publicado: (2019)

Thromboembolic events in metastatic testicular cancer treated with cisplatin-based chemotherapy
por: Shields, Lisa B E, et al.
Publicado: (2021)

Molecular Basis of Cisplatin Resistance in Testicular Germ Cell Tumors
por: Bakardjieva-Mihaylova, Violeta, et al.
Publicado: (2019)

Mechanisms of cisplatin sensitivity and resistance in testicular germ cell tumors
por: Singh, Ratnakar, et al.
Publicado: (2019)

Risk stratification for venous thromboembolism in patients with testicular germ cell tumors
por: Bezan, Angelika, et al.
Publicado: (2017)

Association of metallothionein expression and clinical response to cisplatin based chemotherapy in testicular germ cell tumors
por: Tuzel, Emre, et al.
Publicado: (2015)

Platelet Count Measured Prior to Cancer Development Is a Risk Factor for Future Symptomatic Venous Thromboembolism: The Tromsø Study
por: Jensvoll, Hilde, et al.
Publicado: (2014)

White Blood Cell Count Measured Prior to Cancer Development Is Associated with Future Risk of Venous Thromboembolism – The Tromsø Study
por: Blix, Kristine, et al.
Publicado: (2013)

The Role of TP53 in Cisplatin Resistance in Mediastinal and Testicular Germ Cell Tumors
por: Timmerman, Dennis M., et al.
Publicado: (2021)

Predictors of Venous Thromboembolism in Patients With Testicular Germ Cell Tumors: A Retrospective Study
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2021)

A bibliometric analysis of testicular germ cell tumor research from 2000 to 2020
por: Wang, Chengyuan, et al.
Publicado: (2021)

Efficacy of HDAC Inhibitors Belinostat and Panobinostat against Cisplatin-Sensitive and Cisplatin-Resistant Testicular Germ Cell Tumors
por: Lobo, João, et al.
Publicado: (2020)

Cisplatin Resistance in Testicular Germ Cell Tumors: Current Challenges from Various Perspectives
por: Lobo, João, et al.
Publicado: (2020)

Serum miR371 in testicular germ cell cancer before and after orchiectomy, assessed by digital-droplet PCR in a prospective study
por: Myklebust, Mette Pernille, et al.
Publicado: (2021)

Anti-tumour activity of two novel compounds in cisplatin-resistant testicular germ cell cancer
por: Nitzsche, B, et al.
Publicado: (2012)

Differential gene expression in cisplatin-resistant and -sensitive testicular germ cell tumor cell lines
por: Roška, Jan, et al.
Publicado: (2020)

Testicular Germ Cell Tumors Acquire Cisplatin Resistance by Rebalancing the Usage of DNA Repair Pathways
por: Caggiano, Cinzia, et al.
Publicado: (2021)

Testicular germ cell tumors
por: Albers, Peter
Publicado: (2021)

Cisplatin-induced apoptosis in human malignant testicular germ cell lines depends on MEK/ERK activation
por: Schweyer, S, et al.
Publicado: (2004)

Association between ERCC1 and XPA expression and polymorphisms and the response to cisplatin in testicular germ cell tumours
por: Mendoza, J, et al.
Publicado: (2013)

Genome-scale CRISPR screen reveals neddylation to contribute to cisplatin resistance of testicular germ cell tumours
por: Funke, Kai, et al.
Publicado: (2023)

Prechemotherapy Not Preorchiectomy Serum Tumor Markers Accurately Identify International Germ Cell Cancer Collaborative Group Prognostic Groups in Nonseminoma
por: Fankhauser, Christian D., et al.
Publicado: (2023)

Integrated Microarray-Based Data Analysis of miRNA Expression Profiles: Identification of Novel Biomarkers of Cisplatin-Resistance in Testicular Germ Cell Tumours
por: Roška, Jan, et al.
Publicado: (2023)

Role of MEK/ERK pathway in the MAD2-mediated cisplatin sensitivity in testicular germ cell tumour cells
por: Fung, M K L, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_j8a2cnh0c2kgd91givhv9054cf